With the growing prevalence of neurological disorders, from Parkinson’s and chronic pain to Alzheimer’s, rapid innovation in neuromodulation is more important than ever.

Digital health solutions that connect patients to the care they need have tremendous promise to help reduce healthcare disparities.

The Health Economics and Market Access (HEMA) group at Boston Scientific works to ensure that patients have access to innovative healthcare treatments.

Cleaning an endoscope is a time-intensive process that puts vulnerable patients at risk for infection. Our Endoscopy R&D team developed a solution.

A Boston Scientific R&D leader reflects on the ways a company - even a global corporation - can remain agile, flexible and innovative.

Learn why Boston Scientific is ranked a top industry supporter of historically Black colleges and universities (HBCUs) and about our commitment to diversity.

More than 70% of men over age 70 are affected by enlarged prostate (BPH). Learn how one patient’s symptoms resolved after water vapor therapy with Rezūm,

Prostate cancer treatment can result in side effects like incontinence. Learn why an artificial urinary sphincter implant helped Steve feel like himself again.

Boston Scientific clinical research deliberately recruits from previously underrepresented groups to better reflect populations affected by PAD

The latest advancement from Boston Scientific neuromodulation, the WaveWriter Alpha spinal cord stimulator can offer relief for people living with chronic pain.